Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company Liquidation

LCC Therapeutics LTD.

LCC Therapeutics LTD. is a UK company (number 08900140, status: liquidation), incorporated 2014, with 3 current directors including Deepbridge NED Limited and Thomas Hardman. Source: Companies House, updated 4th October 2026.

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is LCC Therapeutics LTD.. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 16

  1. Dr Steven Powell 2024-2025 Director View profile
  2. Stuart Jason Noble 2020-2023 Director View profile
  3. Andrew Edward Round 2019-2022 Director View profile
  4. Malcolm James Stewart 2018-2024 Director View profile
  5. Michael James Fletcher 2018-2019 Director View profile
  6. Philip John Tottey 2018-2019 Director View profile
  7. Professor Jianliang Xiao 2017-2018 Director View profile
  8. Dr Stephen Barry Parker 2017-2018 Director View profile
  9. Gary Ambrose 2016-2017 Director View profile
  10. Dr Savvas Ioannou Neophytou 2016-2020 Director View profile
  11. Bernard Jason Ross 2016-2018 Director View profile
  12. Dr David Charles Lathbury 2015-2016 Director View profile
  13. Cailing Jiang 2015-2021 Director View profile
  14. Dr Jianjun Wu 2014-2018 Director View profile
  15. Dr Jiwu Ruan 2014-2018 Director View profile
  16. Dr Paul John Joseph Colbon 2018-2022 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

Incorporated
18/02/2014

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. LCC Therapeutics LTD. is controlled by Paul John Joseph Colbon
    Evidence
    ceased significant influence · notified 2016-04-06, ceased 2017-03-04 · source: Companies House PSC register

Ultimately controlled by Paul John Joseph Colbon.

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

8.1y median 8.1y
average tenure
12.4y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (1)

Portfolio (1)

0
also govern a charity
0
left in the last 12 months
1
corporate seats

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
08900140
Status
Liquidation
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data